Pediatric Endocrinology Division Faculty

Robert Ferry, Jr., M.D.

Robert Ferry, Jr., M.D.

Professor of Pediatrics

Medical School: The University of Texas Health Science Center at San Antonio, San Antonio, TX

Pediatric Residency: The University of Texas Health Science Center at San Antonio, San Antonio, TX

Pediatric Endocrinology Fellowship: The Children's Hospital of Philadelphia, Philadelphia, PA

Board Certification: American Board of Pediatrics, American Board of Pediatrics, Sub Board of Pediatric Endocrinology

Awards and Honors: Recognized in 2012 US News & World Report Top Doctors, Listed in Who's Who in America; Listed in Who's Who in Medicine and Healthcare; Named one of America's Top Pediatricians by the Consumers Research Council of America; Lieutenant Colonel, U.S. Army National Guard; American College of Surgeons Committee on Trauma

Recent Peer Reviewed Publications

  1. Vasylyeva TL, Ferry RJ Jr. Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy. Diabetes Research & Clinical Practice 2007;76:177-186.
  2. Rodon J, DeSantos V, Kurzrock R, Ferry RJ Jr. Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials. Molecular Cancer Therapeutics 2008;7:2575-2588.
  3. Melamed E, Wyatt LE, Padilla T, Ferry RJ Jr. Patient-based cultural competency curriculum for pre-health professionals. Family Medicine 2008;40:724-731.
  4. Schlabritz-Loutsevitch NE, Lopez-Alvarenga JC, Comuzzie AG, Miller M, Ford S, Li C, Hubbard GB, Ferry RJ Jr, Nathanielsz PW. The prolonged effect of repeated maternal glucocorticoid exposure on maternal and fetal leptin/insulin-like growth factor axis in Papio spp. Reproductive Sciences 2009;16:308-319. [2009 Impact Factor 2.314]
  5. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nature Genetics 2009;41:703-707. [2009 Impact Factor 34.284]
  6. Hilner JE, Perdue LH, Sides EG, Pierce JJ, Wägner AM, Aldrich A, Loth A, Albret L, Wagenknecht LE, Nierras C, Akolkar B; Type 1 Diabetes Genetics Consortium. Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC). Clinical Trials 2010;7:S5-S32. [2009 Impact Factor 1.917]
  7. Joyce ED, Nolan VG, Ness KK, Ferry RJ Jr, Robison LL, Pui C-H, Hudson MM, Kaste SC. Association of muscle strength and bone mineral density in adult survivors of childhood acute lymphoblastic leukemia. Archives of Physical Medicine and Rehabilitation 2011; 92:873-879. [2009 Impact Factor 2.184]
  8. Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG, for the Protégé Trial Investigators. Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial. The Lancet 2011;378:487-497. [2009 Impact Factor 30.758]
  9. Barone JV, Tillman E, Ferry RJ Jr. Treatment of transient diabetes mellitus with subcutaneous glargine insulin in a neonate with extremely low birth weight. The Journal of Pediatric Pharmacology and Therapeutics: in press.
  10. Samson JE, Mari G, Dick EJ Jr, Hubbard GB, Ferry RJ Jr, Schlabritz-Loutsevitch NE. The morphometry of materno-fetal oxygen exchange barrier in a baboon model of obesity. Placenta 2011;32:845-851. [2011 Impact Factor 2.767]
  11. Hunt KA, Smyth DJ, Balschun T, Ban M, Mistry V, Ahmad T, Anand V, Barrett JC, Bhaw-Rosun L, Bockett NA, Brand OJ, Brouwer E, Concannon P, Cooper JD, Dias KR, van Diemen CC, Dubois PC, Edkins S, Fölster-Holst R, Fransen K, Glass DN, Heap GA, Hofmann S, Huizinga TW, Hunt S, Langford C, Lee J, Mansfield J, Marrosu MG, Mathew CG, Mein CA, Müller-Quernheim J, Nutland S, Onengut-Gumuscu S, Ouwehand W, Pearce K, Prescott NJ, Posthumus MD, Potter S, Rosati G, Sambrook J, Satsangi J, Schreiber S, Shtir C, Simmonds MJ, Sudman M, Thompson SD, Toes R, Trynka G, Vyse TJ, Walker NM, Weidinger S, Zhernakova A, Zoledziewska M; Type 1 Diabetes Genetics Consortium; UK Inflammatory Bowel Disease (IBD) Genetics Consortium; Wellcome Trust Case Control Consortium, Weersma RK, Gough SC, Sawcer S, Wijmenga C, Parkes M, Cucca F, Franke A, Deloukas P, Rich SS, Todd JA, van Heel DA. Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nature Genetics 2011;44:3-5. [2010 Impact Factor 36.377]

Division of Pediatric Endocrinology

Children's Foundation
Research Center
50 N. Dunlap Street, Room 654
Memphis, TN 38103
Phone: 901-287-6034
Fax: 901-287-6337

Program Coordinator:
Rhonda Gray
Email: rgray25@uthsc.edu